The Analyst Verdict: Onto Innovation In The Eyes Of 4 Experts

Oct 1, 2024 · Analysts have recently evaluated Onto Innovation and provided 12-month price targets. The average target is $258.75, accompanied by a high estimate of $275.00 and a low …

CouponFollow Extension

$258.75
OFF

The Analyst Verdict: Onto Innovation In The Eyes Of 4 Experts

3 weeks from now

Oct 1, 2024 · Analysts have recently evaluated Onto Innovation and provided 12-month price targets. The average target is $258.75, accompanied by a high estimate of $275.00 and a low …

nasdaq.com

$540.75
OFF

The Analyst Verdict: Teledyne Technologies In The Eyes Of 4 Experts

3 weeks from now

Dec 10, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $540.75, a high estimate of $585.00, and a low …

nasdaq.com

83%
OFF

The Analyst Verdict: Varonis Systems In The Eyes Of 4 Experts

3 weeks from now

Jul 11, 2024 · Witnessing a positive shift, the current average has risen by 4.83% from the previous average price target of $51.75. Deciphering Analyst Ratings: An In-Depth Analysis

businessinsider.com

$470.25
OFF

The Analyst Verdict: Bio-Rad Laboratories In The Eyes Of 4 Experts

3 weeks from now

Jan 14, 2025 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $470.25, along with a high estimate of $481.00 and a low …

nasdaq.com

$222.43
OFF

The Analyst Verdict: IBM In The Eyes Of 7 Experts | Nasdaq

3 weeks from now

Jan 28, 2025 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $222.43, a high estimate of $260.00, and a low estimate of $160.00.

nasdaq.com

$113
OFF

The Analyst Verdict: Itron In The Eyes Of 10 Experts

3 weeks from now

Jul 11, 2024 · Analysts have set 12-month price targets for Itron, revealing an average target of $113.2, a high estimate of $130.00, and a low estimate of $102.00.

businessinsider.com

26%
OFF

The Analyst Verdict: VSE In The Eyes Of 7 Experts - Nasdaq

3 weeks from now

Dec 6, 2024 · Innovation Answered; Live From MarketSite; ... The Analyst Verdict: VSE In The Eyes Of 7 Experts December 06, 2024 — 12:01 pm EST ... With a net margin of 4.26%, the …

nasdaq.com

$90
OFF

The Analyst Verdict: Microchip Technology In The Eyes Of 4 Experts

3 weeks from now

Nov 6, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Microchip Technology, presenting an average target of $90.0, a high estimate of $100.00, and a low …

nasdaq.com

$15
OFF

The Analyst Verdict: Viasat In The Eyes Of 4 Experts | Nasdaq

3 weeks from now

Nov 20, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $15.5, along with a high estimate of $19.00 and a low estimate …

nasdaq.com

$15.75
OFF

The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts

3 weeks from now

Oct 4, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Inovio Pharmaceuticals, presenting an average target of $15.75, a high estimate of $33.00, and a low …

nasdaq.com

4%
OFF

The Analyst Verdict: NVIDIA In The Eyes Of 33 Experts

3 weeks from now

Nov 11, 2024 · As of 31 July, 2024, the company achieved an impressive revenue growth rate of 122.4%. This signifies a substantial increase in the company's top-line earnings.

nasdaq.com

24%
OFF

The Analyst Verdict: DraftKings In The Eyes Of 14 Experts

3 weeks from now

Jan 7, 2025 · Witnessing a positive shift, the current average has risen by 4.24% from the previous average price target of $50.43. Diving into Analyst Ratings: An In-Depth Exploration

nasdaq.com

$18
OFF

The Analyst Verdict: SI-BONE In The Eyes Of 4 Experts

3 weeks from now

Nov 20, 2024 · Analysts have recently evaluated SI-BONE and provided 12-month price targets. The average target is $18.0, accompanied by a high estimate of $19.00 and a low estimate of …

nasdaq.com

FAQs about The Analyst Verdict: Onto Innovation In The Eyes Of 4 Experts Coupon?

How do analysts evaluate Varonis Systems's stock?

Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Varonis Systems's stock. This examination reveals shifts in analysts' expectations over time. Capture valuable insights into Varonis Systems's market standing by understanding these analyst evaluations alongside pertinent financial indicators. ...

How do financial analysts perceive Itron?

The perception of Itron by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. ...

How do analysts enhance their evaluations?

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights. ...

Why do analysts compare current and prior targets?

Comparing current and prior targets offers insights into analysts' evolving expectations. Capture valuable insights into Itron's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table. Stay up to date on Itron analyst ratings. ...

How do analysts evaluate Nvidia's stock?

Price Targets: Analysts provide insights into price targets, offering estimates for the future value of NVIDIA's stock. This comparison reveals trends in analysts' expectations over time. Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of NVIDIA's market position. ...

Do analysts make a good forecast?

Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts. ...